Levetiracetam Ratiopharm

Levetiracetam, the active ingredient in Levetiracetam Ratiopharm, is an Anticonvulsant presented as an oral tablet for oral use. It is used to treat various seizure types in patients with epilepsy. Levetiracetam Ratiopharm is prescribed for partial, generalized tonic‑clonic and myoclonic seizures.

GNH USA supplies Levetiracetam Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic medication indicated for several seizure disorders. - Partial seizures: reduces the frequency of focal onset seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes. - Myoclonic seizures: decreases sudden muscle jerks associated with epilepsy.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired. - Headache: mild to moderate pain. - Irritability: increased mood swings. - Nausea: occasional stomach upset. - Nasal congestion: mild blockage of nasal passages.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood changes: depression or suicidal thoughts. - Blood disorders: low white blood cell count. - Liver enzyme elevation: abnormal liver function tests. - Severe skin reactions: Stevens‑Johnson syndrome. - Multi‑organ involvement: rare systemic effects.

Patients should be aware of specific safety considerations when using Levetiracetam. - Renal impairment: dose may need adjustment in reduced kidney function. - Psychiatric history: monitor for mood changes or depression. - Concomitant CNS depressants: increased sedation risk. - Pregnancy: discuss potential risks with a healthcare provider. - Breastfeeding: evaluate benefits versus potential infant exposure. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma levels. - Phenobarbital: may reduce seizure control.

Moderate Interactions (Monitor Closely): - Valproic acid: possible increase in adverse effects. - Sedatives (benzodiazepines, opioids): enhanced drowsiness. - Antidepressants (SSRIs): monitor mood changes. - Immunosuppressants: observe for altered drug levels.